Stephanie Yee

Stephanie Yee is a seasoned professional in biomarker operations, currently serving as the Clinical Biomarker Operations and Biobank Lead for the US at Galapagos since September 2025. Prior to this role, Stephanie held the position of Associate Director of Biomarker Operations at Century Therapeutics, Inc. from August 2021 to June 2025, following a progression from Senior Manager in the same field. Between 2008 and 2021, Stephanie contributed to the University of Pennsylvania School of Medicine in various capacities, including Scientific Director and Technical Director of the Circulating Tumor Material Core. Additionally, Stephanie was an Editor for American Journal Experts from 2013 to 2016. Stephanie holds an MBA in Organizational Effectiveness, Marketing, and Operations from The Wharton School, a Master of Science in Criminal Justice with a focus on Behavior Analysis from Saint Joseph's University, and a Bachelor of Arts in Biological Basis of Behavior from the University of Pennsylvania.